BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

Completed

Conditions studied: BK Virus (BKV) Viremia

In brief

The objectives of this study is to establish the natural history of BK virus viremia and other possible opportunistic viral pathogens in renal transplants recipients.

Key facts

Study ID

NCT01782209

Run by

University of Alabama at Birmingham

People needed

335

Starts

2014-06-01

Expected to finish

2019-12-01

Last updated by the study team

2020-07-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Renal or renal-pancreas transplant patients who are within 4 weeks and not more than 90 days post-transplant with or without qualifying BKV viremia Age greater than or equal to 18 years; Provides written informed consent.

You may not qualify if…

• Evidence of proven or suspected BKVN by clinical or pathologic diagnostic criteria Loss of renal graft function Initiation of chronic dialysis

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• California Pacific Medical Center — San Francisco, California, United States
• University of Colorado at Denver and HSC — Denver, Colorado, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Washington University, Barnes Jewish Hospital — St Louis, Missouri, United States
• Columbia University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.